home / stock / glue / glue short
Short Information | Monte Rosa Therapeutics Inc. (NASDAQ:GLUE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 841,900 |
Total Actual Volume | 5,334,519 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 42,095 |
Average Short Percentage | 16.98% |
Is there a GLUE Short Squeeze or Breakout about to happen?
See the GLUE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $3.83 | $3.64 | $3.9 | $3.61 | 335,030 | 69,379 | 20.71% |
07-03-2024 | $3.59 | $3.89 | $3.91 | $3.57 | 158,846 | 48,894 | 30.78% |
07-02-2024 | $3.96 | $3.59 | $4.15 | $3.54 | 290,920 | 55,758 | 19.17% |
07-01-2024 | $3.75 | $3.94 | $4.19 | $3.75 | 402,790 | 111,334 | 27.64% |
06-28-2024 | $3.32 | $3.74 | $3.74 | $3.21 | 579,360 | 94,231 | 16.26% |
06-27-2024 | $3.69 | $3.38 | $3.71 | $3.32 | 220,909 | 36,705 | 16.62% |
06-26-2024 | $3.78 | $3.69 | $3.81 | $3.6 | 204,374 | 43,278 | 21.18% |
06-25-2024 | $3.85 | $3.79 | $3.88 | $3.63 | 200,213 | 28,099 | 14.03% |
06-24-2024 | $3.66 | $3.81 | $3.86 | $3.6 | 187,142 | 20,625 | 11.02% |
06-21-2024 | $3.59 | $3.63 | $3.72 | $3.43 | 922,019 | 15,846 | 1.72% |
06-20-2024 | $3.52 | $3.56 | $3.6407 | $3.49 | 198,150 | 33,317 | 16.81% |
06-18-2024 | $3.67 | $3.54 | $3.85 | $3.51 | 200,429 | 32,672 | 16.3% |
06-17-2024 | $3.76 | $3.67 | $3.91 | $3.5 | 228,175 | 24,929 | 10.93% |
06-14-2024 | $3.99 | $3.83 | $4.11 | $3.71 | 283,370 | 107,806 | 38.04% |
06-13-2024 | $4.15 | $4.01 | $4.24 | $3.98 | 168,274 | 12,807 | 7.61% |
06-12-2024 | $4.45 | $4.16 | $4.49 | $4.09 | 120,548 | 14,987 | 12.43% |
06-11-2024 | $3.97 | $4.28 | $4.42 | $3.97 | 147,923 | 16,937 | 11.45% |
06-10-2024 | $3.94 | $4.02 | $4.1706 | $3.91 | 158,784 | 24,267 | 15.28% |
06-07-2024 | $4.12 | $3.98 | $4.12 | $3.9 | 215,714 | 30,510 | 14.14% |
06-06-2024 | $4.16 | $4.19 | $4.26 | $3.92 | 111,549 | 19,519 | 17.5% |
News, Short Squeeze, Breakout and More Instantly...
Monte Rosa Therapeutics Inc. Company Name:
GLUE Stock Symbol:
NASDAQ Market:
Monte Rosa Therapeutics Inc. Website:
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, will participate in a fireside cha...
Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using a 21/7 schedule; currently assessing 0.75 mg dose level; final determination of recommended Phase 2 dose and updated clinical results anticipated in H2 202...
MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in mid-year 2024 with initial clinical data expected ...